Proxima Aims to Fill CRO Gap for Houston’s Growing Biotech Community | Angela Shah | 03/14/18 | Texas |
Houston Biotech Oncolix Announces Reverse Merger, Goes Public | Angela Shah | 08/07/17 | Texas |
Bio Roundup: BCRA Fireworks, Shkreli Muzzled, Endo Pulls Drug & More | Frank Vinluan | 07/07/17 | National |
Acer Therapeutics Announces Reverse Merger With Houston’s Opexa | Angela Shah | 07/05/17 | Texas |
Opexa Tries a Personalized Cell Therapy Against Last, Worst Stage of MS | Bernadette Tansey | 05/02/13 | Texas |